Boron neutron capture therapy (BNCT) selectively destroys human clear cell sarcoma in mouse model

Takuya Fujimoto, Tooru Andoh, Tamotsu Sudo, Ikuo Fujita, Hiroshi Moritake, Tohru Sugimoto, Toshiko Sakuma, Toshihiro Akisue, Shinji Kawabata, Mitsunori Kirihata, Minoru Suzuki, Yoshinori Sakurai, Koji Ono, Yoshinobu Fukumori, Masahiro Kurosaka, Hideki Ichikawa

Research output: Contribution to journalArticlepeer-review

10 Citations (Scopus)

Abstract

Clear cell sarcoma of tendons and aponeuroses (CCS) is a rare malignant tumor with no effective treatment. This study demonstrates the efficacy of BNCT with the use of human CCS-bearing nude mice. Groups A and C were administered saline, and groups B and D were injected with p-borono- l-phenylalanine-fructose complex. Groups C and D were then irradiated with thermal neutrons. The tumors in only group D disappeared, demonstrating that BNCT is a potentially new option for the treatment of human CCS.

Original languageEnglish
Pages (from-to)96-100
Number of pages5
JournalApplied Radiation and Isotopes
Volume73
DOIs
Publication statusPublished - 03-2013
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Radiation

Fingerprint

Dive into the research topics of 'Boron neutron capture therapy (BNCT) selectively destroys human clear cell sarcoma in mouse model'. Together they form a unique fingerprint.

Cite this